Safe, high-quality clinical studies
With safety as our highest priority, we will work to enhance the diversifying environment for new drug development and will contribute to the improvement of medical care so that new drugs reach patients as quickly as possible.
Our Mission
Greetings from the Chief Director
Medical Corporation Shinanokai is composed of two medical institutions specializing in clinical studies with different features: Shinanozaka Clinic (Director: Kenji Takazawa), which has a track record of over 30 years in clinical studies, and Samoncho Clinic (Director: Masayuki Natani), which is equipped with high-performance facilities for hay fever studies and research.
Medical Corporation Shinanokai was established to ensure stability and persistence in the clinics' medical management and to expand their clinical studies-related business. To solidly achieve these goals, Shinanokai will continue to adapt its implementation structure to the diversifying environment for new drug development, with the safety of clinical study volunteers as the highest priority.
To ensure the practice of "safe, high-quality clinical studies," both clinics will engage in hard work under a spirit of friendly competition to raise the level of their skills.
We will continue our efforts to make new drugs available to patients as quickly as possible and contribute to the enhancement of medical care.
MEDICAL CORPORATION SHINANOKAI
Masami FUJITA, Chief Director
About Us
Executives
| Chief Director | Masami FUJITA |
|---|---|
| Director | Kenji TAKAZAWA (Director,SHINANOZAKA CLINIC) |
| Director | Masayuki NATA (Director,SAMONCHO CLINIC) |
| Auditor | Hirofumi TOMITANI |
Organization
Introduction of the Clinic
Shinanozaka Clinic is a clinical study specialist medical institution. Since its predecessor, Hohsen Clinic, opened in Komagome in 1984, the clinic has built a track record of studies exceeding 40 years. Making the comfort of volunteer subjects a top priority, it conducts clinical studies in a comfortable environment equipped with care rooms, a dining room/common room, and shower rooms.
Samoncho Clinic has conducted clinical trials spanning Phase I to Phase III since its opening in 2005 as a medical institution specializing in clinical studies. At present, it also performs outpatient treatment.
The facility for hay fever study and research, known as the OHIO Chamber, has earned a high reputation internationally for its great contributions to the development of hay fever drugs.